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Objective: Subclinical alterations of cerebral function can occur during or after carotid revascularization and can be
detected by a variety of standard tests. This comparative study assessed the relationship among serum levels for two
biochemical markers of cerebral injury, postoperative diffusion-weighted magnetic resonance imaging (DW-MRI), and
neuropsychometric testing in patients undergoing carotid endarterectomy (CEA) or carotid artery stenting (CAS) for
high-grade asymptomatic carotid stenosis.
Methods: Forty-three consecutive asymptomatic patients underwent carotid revascularization by endarterectomy (CEA,
20) or stenting (CAS, 23). They were evaluated with DW-MRI and the Mini-Mental State Examination (MMSE) test
preoperatively and <24 hours after carotid revascularization. Venous blood samples to assess serum levels of neuron-
specific enolase (NSE) and S100 protein were collected for each patient preoperatively and five times in a 24-hour period
postoperatively and assayed using automated commercial equipment. The MMSE test was repeated at 6 months. The
relationship between serum marker levels and neuropsychometric and imaging tests and differences between the two
groups of patients were analyzed by 2 test, with significance at P < .05.
Results: No transient ischemic attacks or strokes were clinically observed. CAS caused more new subcortical lesions at
postoperative DW-MRI and a significant decline in theMMSE postoperative score compared with CEA (P .03). In CAS
patients, new lesions at DW-MRI were significantly associated with a postoperative MMSE score decline >5 points (P 
.001). Analysis of S100 and NSE levels showed a significant increase at 24 hours in CAS patients compared with CEA
patients (P  .02). The MMSE score at 6 months showed a nonsignificant increase vs the postoperative score in both
groups.
Conclusions: Biochemical markers measurements of brain damage combined with neuropsychometric tests and DW-MRI
can be used to evaluate silent injuries after CAS. The mechanisms of rise in S100 and NSE levels at 24 hours after CAS
may be due to increased perioperative microembolization rather than to hypoperfusion. Further studies are required to
assess the clinical significance of those tests in carotid revascularization. (J Vasc Surg 2010;51:584-92.)Carotid endarterectomy (CEA) is an evidence-based
effective means of preventing strokes in symptomatic and
asymptomatic patients.1 Ongoing trials will definitely state
the role of carotid artery stenting (CAS) compared with
CEA in terms of stroke prevention and low rates of periop-
erative neurologic events.2 Neurologic risk assessment in
major studies is based on the detection of transient ischemic
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584attack (TIA) or stroke, but little is known about subclinical
neurologic morbidity.
Diffusion-weightedmagnetic resonance imaging (DW-
MRI) is effective in detecting new microembolic brain
lesions occurring during or after carotid revascularization.3
Recent studies have focused on the role of microemboliza-
tion after revascularization as causing neurocognitive de-
cline that can be detected by the use of neuropsychometric
tests.4-8 Subclinical neurologic ischemic events can also be
detected by measuring serum markers of brain injury. A
variety of biochemical markers of brain injury have been
described. Among them, neuron-specific enolase (NSE)
and the calcium-binding protein S100 have been demon-
strated to be markers of stroke in animal models9-10 and in
humans.11-17
In 1965Moore isolated a subcellular fraction frombovine
brain, which was thought to contain nervous-system specific
proteins. This fraction was called S100 because the constit-
uents were soluble in 100% saturated ammonium sulfate at
neutral pH. Subsequent studies demonstrated that this frac-
tion contained predominantly two polypeptides, S100Al and
S100, which have molecular weights of approximately
10,000 Da and contain two high-affinity EF-hand calcium-
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cause in the mid-1980s, Kligman and Marshak identified a
purified protein molecule that exhibited neurite extension
factor (NEF) activity when applied to primary chick cortical
neuron cultures as S100.18 The estimated biologic half-
life of S100 is about 2 hours, and maximum levels of the
protein can be detected as early as 20 minutes after brain
injury.19
Neuron-specific enolase (NSE) is a glycolytic enzyme
that is foundmainly in the cytoplasm of neurons and cells of
neuroendocrine origin.20 It has also been found in eryth-
rocytes and platelets, although in smaller concentrations,
but the isoforms  and  are released from neurons after
infarction. They have a molecular weight of 78 kDa and a
biologic half-life in serum of 20 hours.21,22
The aim of this preliminary comparative study was to
assess the relationship between serum levels of S100 and
NSE and postoperative DW-MRI and Mini-Mental State
Examination (MMSE) score in two groups of patients
undergoing carotid revascularization by CEA or CAS.
METHODS
All patients who participated in this study gave in-
formed, written consent. The study protocol was approved
by the local Ethical Research Committee.
Patients. Between April and September 2008, 43 con-
secutive asymptomatic patients undergoing elective carotid
revascularization were recruited to participate in this pro-
spective study. Inclusion criteria were the presence of a
carotid stenosis 70% (European Carotid Surgery Trial
stenosis evaluation criteria),23 with no previous neurologic
symptoms referred in the medical history and the absence
of a previous brain ischemic lesion detected at DW-MRI.
Patients with symptomatic carotid lesions, previous isch-
emic lesions detected at DW-MRI, or inability to give
consent were excluded from the study.
All patients underwent duplex ultrasound imaging and
computed tomography (CT) angiography to assess ana-
tomic suitability for CEA or CAS and were clinically eval-
uated by independent neurologists and cardiologists before
and after treatment. Patients were allocated in the two treat-
ment groups according to clinical and anatomic criteria.
Exclusion criteria for CAS were tortuous or highly
calcified arteries, ostial lesion of the common carotid or
brachiocephalic artery, poor entry points at the femoral
artery, length of the target lesion requiring more than one
stent, presence of intraluminal thrombus or hypo-anechoic
plaque composition, history of bleeding disorder, or intra-
cranial aneurysm or hemorrhage. Exclusion criteria for
CEA were clinically significant cardiac disease (congestive
heart failure, abnormal stress test, or need for open-heart
surgery), severe pulmonary disease, contralateral carotid
occlusion, contralateral laryngeal-nerve palsy, previous ra-
dial neck surgery or radiotherapy to the neck, or recurrent
stenosis.
Demographic and clinical characteristics such as age,
gender, hypertension, smoking habits, diabetes, hyperli-
pemia, coronary artery disease (documented by the pres-ence of previous myocardial infarction, coronary artery
bypass grafting, or history of angina), chronic obstructive
pulmonary disease, side of carotid lesion, contralateral ca-
rotid occlusion, stenosis percentage, and plaque composi-
tion, were recorded and compared between the two treat-
ment groups. Plaque composition was evaluated by gray
scale median score.24 Demographic and clinical data are
listed in Table I.
Carotid endarterectomy. A locoregional cervical block
involving the rami of C2 to C4 was used for CEA in all 20
cases. Routine physiologic monitoring included pulse oxime-
try, electrocardiogram, and invasive blood pressure mea-
surement through the radial artery. Before the internal
carotid artery (ICA) was clamped, heparin (5000  2500
IU depending on body weight) was injected intravenously.
Neurologic status assessment was performed by using the
contralateral “hand grip” test and consciousness assessment
throughout the entire procedure, avoiding any sedative use.
CEA was performed by standard surgical protocol. The
patient was placed supine with the neck turned to the
opposite side and extended. A 7- to 8-cm incision wasmade
along the anterior border of the sternocleidomastoid, equi-
distant from the mastoid and the sternoclavicular joint and
extending caudal or cephalad depending on the site of the
bulb. The platysma muscle and intervening connective
tissue were incised using electrocautery. The sternocleido-
mastoid muscle and the internal jugular vein were retracted
laterally to expose the carotid artery. The internal (ICA),
common (CCA), and external carotid arteries (ECA) were
dissected circumferentially beyond the level of the plaque.
After the ECA and the superior thyroid artery were
Table I. Demographic and clinical data for carotid
endarterectomy and stenting groups
Variable CEA CAS P
Patients, No. 20 23
Age, mean  SD, y 70.1  7.2 71.7  7.2 .67
Sex .16
Males, No. (%) 14 (70) 13 (56.5)
Females 6 10
Left side stenosis, No. (%) 11 (55) 12 (52.2) .54
Contralateral occlusion,
No. (%) 0 4 (17.4) .07
Stenosis, mean  SD % 77  7.32 73.9  4.99 .11
Hyperechoic plaque, No. (%) 16 (80) 22 (95.7) .11
Hypertension, No. (%) 17 (85) 20 (87) .33
Smoking, No. (%) 12 (60) 10 (43.5) .21
Diabetes, No. (%) 8 (40) 13 (56.5) .13
Hyperlipemia, No. (%) 10 (50) 8 (34.8) .24
CAD,a No. (%) 4 (20) 12 (52.2) .03
COPD, No. (%) 6 (30) 12 (52.2) .12
CAD, coronary artery disease; CAS, carotid artery stenting; CEA, carotid
endarterectomy; COPD, Chronic obstructive pulmonary disease; SD, stan-
dard deviation.
Boldface type MMSE scores obtained in CAS patients presenting with new
ischemic lesions at DW-MRI.
aIncludes previous ischemic myocardial infarction, coronary artery bypass
grafting, and history of angina.clamped, the CCA was clamped to assess neurologic func-
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neurologic status assessment, the ICA was clamped and
full-thickness circumferential mobilization of the CCA,
bulb, and ICA was performed. A longitudinal arteriotomy
on the posterior-lateral side of the bifurcation was per-
formed, and the plane for endarterectomy was developed
longitudinally and circumferentially.
The plaque was elevated and transacted in the middle.
The plaque on the ECAwas removed by traction and partial
eversion; the plaque on the CCA was then extracted by
eversion and transection of the plaque flush with the
everted edge. On the ICA, the plaque was pinched and
removed from the vessel. The end point was carefully
inspected for semi-adherent fibers, which were easily rec-
ognized by irrigating with heparinized saline.
Before the arteriotomy was closed, a temporary “flash-
ing” from the ICAwas made, thus allowing the backflow to
drive out loose debris. Dacron patch angioplasty was per-
formed in 80% of cases using 5-0 polypropylene suture in a
semi-continuous fashion, and direct closure was made in a
continuous fashion in 20%. Near closure, the clamps were
temporarily released, thereby flashing the vessel of loose
debris. On completion of the anastomosis, the ECA was
opened to allow debris from the CCA to enter this system
rather than the ICA system. A shunt was used in two
patients (10%). Patients were maintained postoperatively
under their scheduled aspirin (100 mg) or ticlopidine (250
mg) medication.
Carotid artery stenting. CAS was performed with
local anesthesia with continuous control of heart frequency,
blood pressure, and partial pressure of arterial oxygen in all
23 cases. Blood pressure was measured during the entire
procedure by a sphygmomanometer with automated cuff
inflation. Neurologic status was monitored using the con-
tralateral “hand grip” test during and after all catheter
manipulations and avoiding the use of any sedatives before
or during the procedure. Patients received aspirin (100mg)
and clopidogrel (75 mg) at least 24 hours preoperatively
and on the day of the procedure.
A transfemoral approach through a 6F to 7F arterial
sheath was established. Angiography was performed using
diluted nonionic contrast media (70% contrast, 30% saline
solution) and digital subtraction. An initial intravenous
heparin bolus (5000 IU) was administered, followed by a
continuous intra-arterial infusion of heparinized saline so-
lution (5000 IU in 1000mL of saline) through the guiding
catheter.
The common carotid artery was entered with a 6F to 7F
guiding catheter, followed by an angled 0.035-inch hydro-
philic guidewire. A selective angiogram of the carotid artery
and its intracranial branches was obtained to document
length and degree of the stenosis and carotid arteries diam-
eters. A FilterWire (Boston Scientific, Natick, Mass) em-
bolic protection device and Wallstent (Boston Scientific)
were used in all patients. Stent size was chosen according to
an estimation of the carotid artery diameters and the kind of
lesion at ultrasound detection and confirmed by CT an-
giography. Stent deployment was not proceeded by predi-lation and was routinely followed by dilation of the lesion
using a 5- to 6-mm-diameter balloon catheter and a pres-
sure of 6 to 10 atm for a maximum of 5 seconds. Intrave-
nous atropine (1 mg) was administered immediately before
balloon inflation to prevent reflex bradycardia or asystole.
Selective control angiograms were obtained after stent-
ing to confirm a final adequate dilation of the stenotic
segment and no occurrence of local complications such as
dissection and to evaluate the patency of the intracranial
arteries. Technical success was achieved in all cases. Patients
were maintained under lifelong aspirin (100 mg) and addi-
tional clopidogrel (75 mg) for 6 weeks after the procedure.
Neuroradiologic examination. All patients under-
went DW-MRI preoperatively and at 24 hours postopera-
tively. No patient in this series showed ischemic lesions at
the preoperative DW-MRI.
Neuropsychometric assessment. Patients were as-
sessed with the MMSE test (Appendix, online only) before
the operation, 24 hours postoperatively, and at the
6-month follow-up visit. The research assistant (A. R.)
responsible for performing the MMSE preoperatively and
postoperatively in all patients was trained to administer and
score the test. Downgrading in the postoperative examina-
tion, such as from normal to some cognitive impairment (1
step) or a difference 5 in the postoperative score com-
pared with the preoperative value was considered signifi-
cant. No psychotropic or sedative medications were admin-
istered to the patients before performing tests.
Serum biomarkers of brain injury. Venous blood
samples were obtained for each patient preoperatively
(basal sample), at 5 minutes after declamping the ICA or
embolic protection device retrieval, and at 2, 6, 12, and 24
hours after the end of the procedure. Samples were allowed
to clot. After centrifugation (1800g for 6 minutes) 20
minutes from collection, serum was stored at 80°C for
later analysis. S100 and NSE proteins were analyzed by
the use of automated immunoluminometric assays (S100
Elecsys test, Roche Diagnostics GmbH, Mannheim, Ger-
many; ELSA-NSE, CIS Bio International, Gif-sur-Yvette
Cedex, France). The S100 test measures the -subunit of
protein S100 as defined by three monoclonal antibodies
with a detection limit of 0.02 g/L. NSE measurement is
based on monoclonal antibodies that bind to the -subunit
of the enzyme with a minimal measurable concentration of
0.3 g/L. The biochemist (P. M.) who performed the
blood samples analysis was blinded to the treatment group
and imaging test data.
Statistical analysis. The 2 test, unpaired t test for
multiple comparisons, and the Fisher exact test (95% con-
fidence interval) were used to assess differences in demo-
graphic and clinical data, MMSE scores, presence of new
lesions on DW-MRI, and serum biomarkers levels between
the two treatment groups. Continuous values were ex-
pressed as mean  standard deviation.
For each treatment group we identified patients with
new lesions on DW-MRI or a significant (1-step) decrease
on the postoperative MMSE score and analyzed the corre-
lation between new lesions on DW-MRI, MMSE score
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within and between groups was performed with the 2 test
and the Fisher exact test for categoric data. Analysis of
continuous values of brain injury markers was performed
with the adjusted t test for multiple comparisons. We
primarily considered the within variation in markers of
brain injury (S100 and NSE) in patients by comparing
each value with the basal sample and 24-hour values with
the 12-hour values.We considered significant an increase of
25% from the reference value. Results were subsequently
stratified as stable, increased, or decreased in each patient
and then analyzed as belonging to these three groups for
within-group and between-group (CAS vs CEA) variation
analysis. The threshold for significance was set at P  .05.
RESULTS
Descriptive results of study population. Twenty pa-
tients underwent CEA and 23 underwent CAS, with a
mean age of 70.1  7.22 and 71.7  7.21 years, respec-
tively. Among preoperative data, coronary artery disease
was significantly more frequent in CAS patients (52.2%) vs
CEA patients (20%; P 	 .03). No patients died in the
perioperative period. Neurologic morbidity was 5% (1 tem-
porary cranial nerve lesion) in the CEA group and 0% in the
CAS group. Two groin hematomas (8.7%) were recorded
in the CAS group.
Table II. Diffusion-weighted magnetic resonance imaging
preoperatively, postoperatively, and at 6 months
Coronary artery stenting
Pt
DW-MRI MMSE score
Pre Post Pre Post 6 mon
1   24 19 20
2   15 13 13
3   30 27 27
4   25 19 18
5   30 28 28
6   25 26 23
7   29 27 27
8   29 24 27
9   27 17 25
10   28 28 30
11   26 18 22
12   30 24 20
13   21 21 21
14   16 15 15
15   28 28 28
16   26 22 25
17   30 28 28
18   23 23 23
19   27 21 22
20   30 26 28
21   24 24 24
22   28 28 30
23   18 20 21
Mean 25.6 22.9 23.7
,Negative result;, positive result;DW-MRI, diffusion-weighted magnet
Post, 24 hours postoperatively.
Boldface type MMSE scores obtained in CAS patients presenting with new ischeImaging and neuropsychometric tests. No preoper-
ative ischemic lesions were detected by preoperative DW-
MRI. In five CAS patients (21%), new ischemic lesions were
detected at the 24-hour postoperative DW-MRI, with no
lesion encountered in CEA patients (P 	 .035; Table II).
The mean preoperative MMSE scores were 26.1  3.46
and 25.6 4.46 in the CEA and CAS groups, respectively,
and postoperative scores were 25.6  3.27 and 22.9 
4.54. Within-group analysis revealed a significant decrease
in theMMSE score in the CAS group that was not observed
in the CEA group (P 	 .045 and P 	 .67, respectively).
Between-group analysis showed a significant decrease in
the postoperative score in CAS patients with respect to
CEA patients (P	 .03), with a
5-point decrease in seven
CAS patients (30%) and one CEA patient (5%).
New lesions at DW-MRI in CAS patients were signifi-
cantly associated with the MMSE score decline 
5 points
(P 	 .001); the MMSE scores in those patients were
significantly decreased compared with patients with nega-
tive results on postoperative DW-MRI (P  .001). At the
6-month follow-up, the MMSE score showed an improve-
ment in CAS patients and it was effectively stable in the
CEA group, with a mean score 23.7  4.58 in CAS and
25.9  3.43 in CEA patients (within- and between-group
analysis, P 	 NS). DW-RMI results and MMSE scores are
listed in Table II.
Mini-Mental State Examination evaluations
Carotid endarterectomy
Pt
DW-MRI MMSE score
Pre Post Pre Post 6 mon
1   27 25 25
2   23 27 26
3   30 28 30
4   25 26 26
5   21 25 25
6   30 28 28
7   26 26 25
8   27 23 22
9   16 18 18
10   28 30 28
11   26 24 27
12   25 25 27
13   27 27 26
14   29 28 30
15   23 18 18
16   27 25 25
17   30 29 30
18   30 30 30
19   25 27 27
20   27 24 25
26.1 25.6 25.9
nance imaging;MMSE,Mini-Mental State Examination; Pre, preoperative;and
ic resomic lesions at DW-MRI.
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the NSE and S100 levels from basal through 24 hours
after intervention. Basal NSE and S100 levels were the
0
2
4
6
8
10
12
14
16
Ba
sal
5 m
inu
tes
2 h
ou
rs
6 h
ou
rs
12
 ho
ur
s
24
 ho
ur
s
SD
Mean (ng/mL)
Fig 1. Mean neuron-specific enolase values in carotid artery
stenting patients are shown with the standard deviation (SD).
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Fig 2. Mean neuron-specific enolase values in carotid endarterec-
tomy patients are shown with the standard deviation (SD).
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Fig 3. Mean neuron-specific enolase values are shown in carotid
artery stenting (CAS) and carotid endarterectomy (CEA) patients.same for each group (P 	 .77 and .12, respectively). Weconsidered the variation in the S100 and NSE markers of
brain injury primarily in patients (variation within) and then
between different groups (variation between). Analysis on
continuous values after intervention in CAS group showed
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Fig 4. Mean S100 levels in carotid artery stenting patients are
shown with the standard deviation (SD).
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Fig 5. Mean S100 levels in carotid endarterectomy patients are
shown with the standard deviation (SD).
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Fig 6. Mean S100 levels are shown in carotid artery stenting
(CAS) and carotid endarterectomy (CEA) patients.an increasing trend for all S100 and NSE levels compared
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with the 12-hour level (P	 .072 and P	 .38, respectively,
for S100 and P 	 .004 and P 	 .581 for NSE at within-
group analysis performed by unpaired t test adjusted for
multiple comparisons). This trend was not confirmed in
CEA patients (P 	 .875 and P 	 .824, respectively, for all
values compared with basal value and for the 24-hour value
vs the 12-hour level for S100, and P	 .139 and P	 .292
for NSE). Analysis on continuous values between groups
showed no statistically significant difference except for 6
hours NSE levels (P 	 .042).
Then we divided patients in each treatment group
according to the variation of markers encountered by com-
paring each value with the basal sample and 24-hour value
with 12-hour value. We considered significant an increase
of 25% from the basal value. Results were subsequently
stratified as stable, increased, or decreased in each patient
and then analyzed as belonging to these three groups for
between-groups variation analysis.
In the CAS group, S100 increased by 25% at 12
hours vs baseline and by 25% at 24 hours vs 12 hours in
78% and 83%, respectively. Likewise, such increases in NSE
occurred in 56% and 70% of CAS patients, respectively. In
CEA patients, such S100 increases occurred in 45% and
50% of patients respectively, and 25% NSE increases
occurred in 55% and 35%, respectively. Analysis between
the groups showed a significant number of CAS patients
with increasing 24-hour values vs 12-hour levels of S100
and NSE compared with CEA patients (P 	 .02). All CAS
patients with new lesions on postoperative DW-MRI and
significant decline in the postoperative MMSE score had a
nonsignificant increase in the 24-hour S100 level com-
pared with the basal value.
DISCUSSION
After an ischemic stroke, DW-MRI is highly sensitive to
the changes occurring in the lesion.25 It is speculated that
increases in restriction (barriers) to water diffusion, as a
result of cytotoxic edema (cellular swelling), is responsible
for the increase in signal on a DWI scan. The DWI en-
hancement appears within 5 to 10 minutes of the onset of
stroke symptoms and remains for up to 2 weeks. Coupled
with imaging of cerebral perfusion, it can highlight regions
of “perfusion/diffusion mismatch” that may indicate re-
gions capable of salvage by reperfusion therapy. DWI is able
to detect subclinical neurologic injuries from the very early
onset and has been shown to be positive within minutes of
brain injury in both animals and humans.25,26
CAS for carotid revascularization has been introduced
as an alternative to CEA, which rarely is accompanied by
new lesions on DWI. Some authors27,28 have shown that
new lesions are rarely seen on DWI after CEA. In a com-
parison of CAS and CEA, Roh et al29 found that both
neurologic events and new lesions on DWI were far more
common with CAS. In their study, Rapp et al3 reported a
series of 48 patients undergoing 54 CAS procedures with
excellent clinical outcomes but a concerning number of
new lesions on DW-MRI. These subclinical brain injuriesdid not occur during the procedure but in the ensuing 48
hours, when transcranial Doppler studies had confirmed an
ongoing number of embolic events. Although in the short-
term period new subtle cerebral lesions seem to have no
measurable consequences and by 6 months post-CAS most
have resolved without residual effects, repetitive embolic
injuries, nevertheless, may have a cumulative effect.30 In
our study no ischemic lesions were detected at the preop-
erative DW-MRI; however, new ischemic lesions were de-
tected at the 24-hour postoperative DW-MRI in 21% of
CAS patients, with no lesion encountered in CEA group.
Neuropsychometric tests were developed to detect
subtle changes in higher cortical functioning. The MMSE,
or Folstein test, is a brief 30-point questionnaire that is used
to screen for cognitive impairment and is commonly used
to screen for dementia. It is also used to estimate the
severity of cognitive impairment at a given point in time
and to monitor the course of cognitive changes in an
individual over time, thus making it an effective way to
document an individual’s response to treatment. In the time
span of about 10minutes, it samples various functions, includ-
ing arithmetic, memory, and orientation. The MMSE was
introduced by Folstein et al31 in 1975. The standard MMSE
form that is currently published by Psychological Assessment
Resources is based on its original 1975 conceptualization,
with minor subsequent modifications by the authors.
Various other tests are also used, such as the Hodkin-
son abbreviated mental test score32 as well as longer formal
tests for deeper analysis of specific deficits. The MMSE test
includes simple questions and problems in a number of
areas: the time and place of the test, repeating lists of words,
arithmetic, language use and comprehension, and basic
motor skills; for example, one question asks the individual
to copy a drawing of two pentagons. The test has a poten-
tial score of 30, and any score 
27 is effectively normal.
Below this, 20 to 26 indicates some cognitive impairment,
10 to 19 indicates moderate to severe cognitive impair-
ment, and10 indicates very severe cognitive impairment.
The raw scoremay also be corrected for degree of schooling
and age.33 Low to very low scores correlate closely with the
presence of dementia, although other mental disorders can
also lead to abnormal findings on MMSE testing.
A decline in neuropsychometric test performance can
be reasonably due to clinically silent hypoperfusion or
microembolization occurring during or after carotid revas-
cularization. Although controversial results have been re-
ported by several studies that have addressed the effect of
CEA on cognitive function,4,7,34,35 little is known of the
effect of CAS on neuropsychometric test results. There are
no clear guidelines for judging what is a significant im-
provement or decline when performing a neuropsychomet-
ric test, and patients significantly improve their score with
repeated performances.36
Some patients can experience an improvement in neu-
ropsychometric test performance after CEA. Owens et al37
demonstrated that if patients with 
50% stenosis had nor-
mal CT scans and computerized radionuclide angiograms
before and after CEA, they showed cognitive improvement
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immediate 3 to 10 days after the procedure but deterio-
rated in their cognitive performance if these tests demon-
strated evidence of small infarcts or if there was clinical
evidence of a stroke. Only those with small infarcts im-
proved at later follow-up testing at 3 to 6 months.37 In our
series we noted a significant decline in the postoperative
MMSE score in CAS patients, with some improvement in
the 6-month follow-up score. This finding can probably be
related to the kind of training developed by patients with
repeated performances.
Furthermore, we reported a significant association be-
tween new ischemic lesions on postoperative DW-MRI and
MMSE score decline in CAS patients compared with pre-
procedural values and with patients with no postoperative
ischemic lesions. This may suggest a postprocedural micro-
embolic mechanism involvement in those patients, as stated
in previous reports.3,29,30 Jordan et al38 observed that the
percutaneous angioplasty with stenting procedure is asso-
ciated with more than eight times the rate of microemboli
seen during CEAwhen evaluated with transcranial Doppler
monitoring.
We found increased levels of postoperative S100 and
NSE in CAS patients, and all CAS patients with new lesions
on postoperative DW-MRI and significant decline in post-
operative MMSE score showed an increase of S100 value
at 24 hours compared with the basal value. S100 and NSE
proteins are considered markers of cerebral injuries.5,6,8-22
Because of the S100 short half-life of about 2 hours, the
sustained elevated levels observed in the serum of stroke
patients likely represent ongoing release of the marker by
perishing tissue as the densely ischemic infarction core
expands and recruits marginally viable penumbral tissues
into the enlarging necrotic region so that sustained S100
release occurs with the death of the penumbral tissues.39 As
a consequence, peak S100 serum levels can be sustained
for long periods and can be demonstrated on days 2 to 4
after middle cerebral artery infarctions.11 Because more
extensive cerebral injuries are associated with higher serum
S100 levels with relatively late peak times,17,19 patients
with subclinical cerebral tissue death exhibit lower and
progressively earlier peak serum levels. Kilminster et al39
demonstrated that a mild decline in neuropsychometric test
performance after coronary artery bypass grafting was cor-
related with increased S100 levels measured at 5 hours
after the procedure.
Serum NSE levels have been demonstrated to increase
after cerebral infarctions in patients. Experimental data gained
frommiddle cerebral artery occlusion in a rat model showed a
significant increase of NSE starting 2 hours after focal isch-
emia.9 NSE serum levels correspond to the ischemia-induced
cytoplasmic loss of NSE in neurons and are detectable
before irreversible neuronal damage takes place.5,9,10 The
first NSE peak7 to 18 hours after stroke onset may reflect
the initial damage of neuronal tissue, whereas a second
increase may be attributed to secondary mechanisms of
neuronal damage due to edema and an increase of intracra-
nial pressure. The correlation among NSE levels, cerebralinfarction volume, and early neurobehavioral outcomes
remains controversial.5,13,14,39,40
We analyzed S100 and NSE values as continuous and
categoric (belonging to increased, stable or decreased
groups) data and found that to some degree they can be
considered related to subclinical brain injuries. Our obser-
vations have shown CAS is associated with a higher number
of new ischemic lesions on DW-MRI and an important
decrease in the MMSE score. In CAS patients presenting
with new subclinical injuries, S100 and NSE values expe-
rienced an increasing trend that was not noticed in CEA
patients. These findings, together with time of presenta-
tion, could be related to microembolization rather than to
procedural embolization phenomena in CAS patients de-
spite routine use of embolic protection devices.41
Study limitations. This study assessed the relation-
ship between serum levels of S100 and NSE and postop-
erative DW-MRI and MMSE scores in two groups of
patients who underwent carotid revascularization by CEA
or CAS. Because of the small number of patients assigned in
each treatment group, our results might be considered
preliminary. The ongoing recruitment of patients will
strengthen the statistical power of our results or will con-
fute them. Allocation of patients between the two treat-
ment groups was not randomized according to our inclu-
sion and exclusion criteria for carotid revascularization by
CEA or CAS.
CONCLUSIONS
Because DW-MRI is mainly accepted as the gold
standard in revealing subclinical brain injuries in patients
undergoing carotid revascularization from their very
early onset, the role of neuropsychometric tests and
markers of brain injuries in detecting subclinical ischemic
lesions needs to be assessed in larger series to better
understand their clinical relevance. Nevertheless, our
preliminary study suggests a subclinical but measurably
higher rate of microembolic events in CAS procedures.
Our findings should be further evaluated in a larger
randomized trial.
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